243 related articles for article (PubMed ID: 15458385)
1. Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.
Yates SP; Taylor PL; Jørgensen R; Ferraris D; Zhang J; Andersen GR; Merrill AR
Biochem J; 2005 Feb; 385(Pt 3):667-75. PubMed ID: 15458385
[TBL] [Abstract][Full Text] [Related]
2. Characterization of competitive inhibitors for the transferase activity of Pseudomonas aeruginosa exotoxin A.
Armstrong S; Li JH; Zhang J; Merrill AR
J Enzyme Inhib Med Chem; 2002 Aug; 17(4):235-46. PubMed ID: 12530476
[TBL] [Abstract][Full Text] [Related]
3. Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A.
Armstrong S; Merrill AR
Biochemistry; 2004 Jan; 43(1):183-94. PubMed ID: 14705944
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.
Yates SP; Merrill AR
Biochem J; 2004 May; 379(Pt 3):563-72. PubMed ID: 14733615
[TBL] [Abstract][Full Text] [Related]
5. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
[TBL] [Abstract][Full Text] [Related]
6. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
Beattie BK; Prentice GA; Merrill AR
Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
[TBL] [Abstract][Full Text] [Related]
7. Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis.
Santajit S; Seesuay W; Mahasongkram K; Sookrung N; Ampawong S; Reamtong O; Diraphat P; Chaicumpa W; Indrawattana N
Sci Rep; 2019 Oct; 9(1):14928. PubMed ID: 31624289
[TBL] [Abstract][Full Text] [Related]
8. An enzyme-linked immunosorbent assay for the association of the catalytic domain of diphthamide-specific ribosyltransferases to eukaryotic elongation factor-2.
Prentice GA; Merrill AR
Anal Biochem; 1999 Aug; 272(2):216-23. PubMed ID: 10415091
[TBL] [Abstract][Full Text] [Related]
9. Structural complementation of the catalytic domain of pseudomonas exotoxin A.
Boland EL; Van Dyken CM; Duckett RM; McCluskey AJ; Poon GM
J Mol Biol; 2014 Feb; 426(3):645-55. PubMed ID: 24211469
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
Li M; Dyda F; Benhar I; Pastan I; Davies DR
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6902-6. PubMed ID: 8692916
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa exotoxin A interaction with eucaryotic elongation factor 2. Role of the His426 residue.
Kessler SP; Galloway DR
J Biol Chem; 1992 Sep; 267(27):19107-11. PubMed ID: 1527035
[TBL] [Abstract][Full Text] [Related]
12. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
Wilson BA; Collier RJ
Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
[No Abstract] [Full Text] [Related]
13. The nature and character of the transition state for the ADP-ribosyltransferase reaction.
Jørgensen R; Wang Y; Visschedyk D; Merrill AR
EMBO Rep; 2008 Aug; 9(8):802-9. PubMed ID: 18583986
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.
Li M; Dyda F; Benhar I; Pastan I; Davies DR
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9308-12. PubMed ID: 7568123
[TBL] [Abstract][Full Text] [Related]
15. In vitro enzyme activation and folded stability of Pseudomonas aeruginosa exotoxin A and its C-terminal peptide.
Beattie BK; Merrill AR
Biochemistry; 1996 Jul; 35(28):9042-51. PubMed ID: 8703907
[TBL] [Abstract][Full Text] [Related]
16. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
Han XY; Galloway DR
J Biol Chem; 1995 Jan; 270(2):679-84. PubMed ID: 7822295
[TBL] [Abstract][Full Text] [Related]
17. A catalytic loop within Pseudomonas aeruginosa exotoxin A modulates its transferase activity.
Yates SP; Merrill AR
J Biol Chem; 2001 Sep; 276(37):35029-36. PubMed ID: 11457845
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity.
Saleeb M; Sundin C; Aglar Ö; Pinto AF; Ebrahimi M; Forsberg Å; Schüler H; Elofsson M
Eur J Med Chem; 2018 Jan; 143():568-576. PubMed ID: 29207339
[TBL] [Abstract][Full Text] [Related]
19. A comparative structure-function analysis of active-site inhibitors of Vibrio cholerae cholix toxin.
Lugo MR; Merrill AR
J Mol Recognit; 2015 Sep; 28(9):539-52. PubMed ID: 25756608
[TBL] [Abstract][Full Text] [Related]
20. Application of a fluorometric assay for characterization of the catalytic competency of a domain III fragment of Pseudomonas aeruginosa exotoxin A.
Armstrong S; Merrill AR
Anal Biochem; 2001 May; 292(1):26-33. PubMed ID: 11319814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
